CHENGDU, China, June 6, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating sacituzumab tirumotecan (sac-TMT) versus docetaxel in patients with previously...
Read More Details
Finally We wish PressBee provided you with enough information of ( The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC )
Also on site :
- Adorable Elephant Breaks Free From National Park and Heads Right to the Snack Aisle at the Grocery Store
- Chicago Forecast: Pleasant temperatures, mostly cloudy skies ahead of possible evening rain
- Yemen’s al-Qaida branch leader threatens Trump, Musk and others